Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system

被引:216
作者
Hamilton, Alison [1 ]
Holscher, Christian [1 ]
机构
[1] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland
关键词
hippocampus; long-term potentiation; neurodegeneration; neuroprotection; neurotransmission; DEPENDENT INSULINOTROPIC POLYPEPTIDE; FACILITATE HIPPOCAMPAL LTP; ALZHEIMER-DISEASE; GLUCOSE-METABOLISM; GLP-1; BETA; IMPAIRMENT; REVERSE; BRAIN; AMIDE;
D O I
10.1097/WNR.0b013e32832fbf14
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glucagon-like-peptide-1 is an incretin hormone that also has neuroprotective properties. Here we analyse where glucagon-like-peptide-l receptors are expressed in the brain. The receptor is found only on neurons, not on glia cells. The pyramidal cell layer of the CA region and the granule cell layer of the dentate gyrus in the hippocampus show intense staining. In the neocortex, larger pyramidal neurons express the receptor. In the cerebellum, only Purkinje neurons express the receptor. Dendrites of larger neurons were stained; in particular, pyramidal cells in area CA and dendrites of Purkinje cells. The fact that the receptor is located on neurons and dendrites suggests that the neuroprotective action is caused by the modulation of neuronal excitation. NeuroReport 20:1161-1166 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1161 / 1166
页数:6
相关论文
共 24 条
[1]  
ABBAS T, 2009, BEHAV BRAIN RES
[2]   The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem [J].
Alvarez, E ;
Martínez, MD ;
Roncero, I ;
Chowen, JA ;
García-Cuartero, B ;
Gispert, JD ;
Sanz, C ;
Vázquez, P ;
Maldonado, A ;
de Cáceres, J ;
Desco, M ;
Pozo, MA ;
Blázquez, E .
JOURNAL OF NEUROCHEMISTRY, 2005, 92 (04) :798-806
[3]   Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus [J].
Biessels, GJ ;
De Leeuw, FE ;
Lindeboom, J ;
Barkhof, F ;
Scheltens, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (03) :304-307
[4]   The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease [J].
Carro, E ;
Torres-Aleman, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 490 (1-3) :127-133
[5]   Increased glucagon like peptide-1 receptor expression in glia after mechanical lesion of the rat brain [J].
Chowen, JA ;
de Fonseca, FR ;
Alvarez, E ;
Navarro, M ;
García-Segura, LM ;
Blázquez, E .
NEUROPEPTIDES, 1999, 33 (03) :212-215
[6]   Glucagon-like peptide-1 receptor is involved in learning and neuroprotection [J].
During, MJ ;
Cao, L ;
Zuzga, DS ;
Francis, JS ;
Fitzsimons, HL ;
Jiao, XY ;
Bland, RJ ;
Klugmann, M ;
Banks, WA ;
Drucker, DJ ;
Haile, CN .
NATURE MEDICINE, 2003, 9 (09) :1173-1179
[7]   Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes [J].
Gault, VA ;
Flatt, PR ;
O'Harte, FPM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (02) :207-213
[8]   GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid [J].
Gault, Victor A. ;
Hoelscher, Christian .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 587 (1-3) :112-117
[9]   Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid [J].
Gault, Victor A. ;
Hoelscher, Christian .
JOURNAL OF NEUROPHYSIOLOGY, 2008, 99 (04) :1590-1595
[10]  
GENGLER S, 2008, ANN SOC NEUR M WASH